Efficacy and safety of dual-targeted therapy in children with inflammatory bowel disease: Retrospective cohort study.

World J Clin Pediatr · 2026 · PMC13010580 · PMID 41884046

Europe PMC DOI

hedged sentence

0.2450

closest p · 4.9× alpha

0.2450

boldest claim

The sentences

did not reach statistical significanceP = 0.245not close (p > 0.1)

Multicenter international study by Cohen et al [ 11 ] revealed a trend towards lower rates of CR at 8 weeks of UP monotherapy in the presence of PL, although the difference did not reach statistical significance ( P = 0.245).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.